Imaging of renal cell carcinoma: State of the art and recent advances

Urologia Internationalis

Volumn 86, Issue 2, 2011, Pages 125-139

  Sacco, Emilio ^a   Pinto, Francesco ^a   Totaro, Angelo ^a   D'Addessi, Alessandro ^a   Racioppi, Marco ^a   Gulino, Gaetano ^a   Volpe, Andrea ^a   Marangi, Francesco ^a   D'Agostino, Daniele ^a   Bassi, Pierfrancesco ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Computed tomography; Magnetic resonance imaging; Positron emission tomography; Renal carcinoma; Ultrasonography

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3' FLUOROTHYMIDINE F 18; BEVACIZUMAB ZR 89; CHIMERIC ANTIBODY G250 I 124; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; HYDROGEN 2 O 15; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; SUNITINIB F 18; TRACER; UNCLASSIFIED DRUG;

ANGIOMYOLIPOMA; ANTIANGIOGENIC THERAPY; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; DOPPLER ECHOGRAPHY; FOLLOW UP; GRAY SCALE ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MICROBUBBLE; MICROMETASTASIS; MINIMALLY INVASIVE PROCEDURE; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM METASTASIS; PEROPERATIVE ECHOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR THROMBUS; VEIN EMBOLISM; VENOUS THROMBOEMBOLISM; WHOLE BODY IMAGING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 79952984775     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322724     Document Type: Review

References (152)

1. Jemal A, Siegel R, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, Raghavendra BN: Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989; 170: 699-703. (Pubitemid 19062586)
3. Tsui K, Shvarts O, Smith R, et al: Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000; 163: 426-430. (Pubitemid 30060485)
4. Mihara S, Kuroda K, Yoshioka R, Koyama W: Early detection of renal cell carcinoma by ultrasonographic screening - based on the results of 13 years screening in Japan. Ultrasound Med Biol 1999; 25: 1033-1039. (Pubitemid 29408496)
5. Mueller-Lisse UG, Mueller-Lisse UL: Imaging of advanced renal cell carcinoma. World J Urol 2010; 28: 253-261.
6. Raj GV, Bach AM, Iasonos A, Korets R, Blitstein J, Hann L, Russo P: Predicting the histology of renal masses using preoperative Doppler ultrasonography. J Urol 2007; 177: 53-58. (Pubitemid 44879469)
7. Kitamura H, Fujimoto H, Tobisu K, Mizuguchi Y, Maeda T, Matsuoka N, et al: Dynamic computed tomography and color Doppler ultrasound of renal parenchymal neoplasms: correlations with histopathological findings. Jpn J Clin Oncol 2004; 34: 78-81. (Pubitemid 43115323)
8. Siegel CL, Middleton WD, Teefey SA, Mc- Clennan BL: Angiomyolipoma and renal cell carcinoma: US differentiation. Radiology 1996; 198: 789-793. (Pubitemid 26066300)
9. Yamashita Y, Ueno S, Makita O, Ogata I, et al: Hyperechoic renal tumors: anechoic rim and intratumoral cysts in US differentiation of renal cell carcinoma from angiomyolipoma. Radiology 1993; 188: 179-182. (Pubitemid 23183120)
10. Yamashita Y, Takahashi M, Watanabe O, et al: Small renal cell carcinoma: pathologic and radiologic correlation. Radiology 1992; 184: 493-498.
11. Helenon O, Correas JM, Balleyguier C, et al: Ultrasound of renal tumors. Eur Radiol 2001; 11: 1890-1901. (Pubitemid 32936891)
12. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM: Small < or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198: 785-788.
13. Jinzaki M, Ohkuma K, Tanimoto A, et al: Small solid renal lesions: usefulness of power Doppler US. Radiology 1998; 209: 543-550. (Pubitemid 28503127)
14. Bolton DM, Wong P, Lawrentschuk N: Renal cell carcinoma: imaging and therapy. Curr Opin Urol 2007; 17: 337-340. (Pubitemid 47344621)
15. Shapiro RS, Wagreich J, Parsons RB, Stancato- Pasik A, Yeh HC, Lao R: Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 1998; 171: 1203-1206. (Pubitemid 28489397)
16. Kim AY, Kim SH, Kim YJ, Lee IH: Contrastenhanced power Doppler sonography for the differentiation of cystic renal lesions: preliminary study. J Ultrasound Med 1999; 18: 581-588 (Pubitemid 29411766)
17. Ascenti G, Zimbaro G, Mazziotti S, et al: Doppler power with contrast media in the characterization of renal masses. Radiol Med (Torino) 2000; 100: 168-174.
18. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O: Ultrasound contrast agents: properties, principles of actions, tolerance, and artifacts. Eur Radiol 2001; 11: 1316-1328. (Pubitemid 32755614)
19. Lassau N, Koscielny S, Opolon P, De Baere T, Peronneau P, Leclere J, Roche A: Evaluation of contrast-enhanced color doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol 2001; 36: 50-55. (Pubitemid 32064170)
20. Quaia E: Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17: 1995-2008. (Pubitemid 47097457)
21. Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A: Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment. Target Oncol 2010; 5: 53-38.
22. Ascenti G, Zimbaro G, Mazziotti S, et al: Usefulness of power Doppler and contrastenhanced sonography in the differentiation of hyperechoic renal masses. Abdom Imaging 2001; 26: 654-660. (Pubitemid 33130821)
23. Mazziotti S, Zimbaro F, Pandolfo A, Racchiusa S, Settineri N, Ascenti G: Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 2010; 35: 241-245.
24. Ascenti G, Mazziotti S, Zimbaro G, et al: Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 2007; 243: 158-165. (Pubitemid 46579706)
25. Clevert DA, Minaifar N, Weckbach S, Jung EM, Stock K, Reiser M, Staehler M: Multislice computed tomography versus contrast- enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc 2008; 39: 171-178. (Pubitemid 352039998)
26. Quaia E, Siracusano S, Bertolotto M, Monduzzi M, Mucelli RP: Characterization of renal tumours with pulse inversion harmonic imaging by intermittent high mechanical index technique: initial results. Eur Radiol 2003; 13: 1402-1412. (Pubitemid 36790644)
27. Kim JH, Eun HW, Lee HK, et al: Renal perfusion abnormality: coded harmonic angio-US with contrast agent. Acta Radiol 2003; 44: 166-171.
28. Park BK, Kim SH, Choi HJ: Characterization of renal cell carcinoma using agent detection imaging: comparison with gray-scale US. Korean J Radiol 2005; 6: 173-178. (Pubitemid 41296877)
29. London NJ, Messios N, Kinder RB, Smart JG, Osborn DE, Watkin EM, Flynn JT: A prospective study of the value of conventional CT, dynamic CT, ultrasonography and arteriography for staging renal carcinoma. Br J Urol 1989; 64: 209-217. (Pubitemid 19244781)
30. Bos SD, Mensink HJA: Can duplex Doppler ultrasound replace computed tomography in staging patients with renal cell carcinoma? Scand J Urol Nephrol 1998; 32: 87-91. (Pubitemid 28206797)
31. Spahn M, Portillo FJ, Michel MS, Siegsmund M, Gaa J, Alken P, J̈nemann KP: Color duplex sonography vs. computed tomography: accuracy in the preoperative evaluation of renal cell carcinoma. Eur Urol 2001; 40: 337-342. (Pubitemid 34701906)
32. Ascenti G, Gaeta M, Magno C, Mazziotti S, Blandino A, Melloni D, Zimbaro G: Contrast- enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. AJR Am J Roentgenol 2004; 182: 1525-1530. (Pubitemid 38668857)
33. Van Poppel H, Bamelis B, Oyen R, Baert L: Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol 1998; 160: 674-678. (Pubitemid 29479485)
34. Jiang J, Chen Y, Zhou Y, Zhang H: Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol 2010; 73: 162-167.
35. Habboub HK, Abu-Yousef MM, Williams RD, See WA, Schweiger GD: Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. JR Am J Roentgenol 1997; 168: 267-271. (Pubitemid 27014787)
36. Khan AR, Anwar K, Fatima N, Khan SF: Comparison of CT scan and colour flow Doppler ultrasound in detecting venous tumour thrombous in renal cell carcinoma. J Ayub Med Coll Abbottabad 2008; 20: 47-50.
37. Gupta NP, Ansari MS, Khaitan A, Sivaramakrishna MS, Hemal AK, Dogra PN, Seth A: Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins. Urol Int 2004; 72: 129-134. (Pubitemid 38223797)
38. Trombetta C, Liguori G, Bucci S, Benvenuto S, Garaffa G, Belgrano E: Evaluation of tumor thrombi in the inferior vena cava with intraoperative ultrasound. World J Urol 2007; 25: 381-384.
39. Walther MM, Choyke PL, Hayes W, Shawker TH, Alexander RB, Linehan WM: Evaluation of color Doppler intraoperative ultrasound in parenchymal sparing renal surgery. J Urol 1994; 152: 1984-1987. (Pubitemid 24354707)
40. Choyke PL, Pavlovich CP, Daryanani KD, Hewitt SM, Linehan WM, Walther MM: Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J Urol 2001; 165: 397-400. (Pubitemid 32060421)
41. Sigman DB, Hasnain JU, Del Pizzo JJ, Sklar GN: Real time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy. J Urol 1999; 161: 36-38. (Pubitemid 29422284)
42. Tomita Y, Kurumada S,Takahashi K, Ohzeki H: Intraoperative transesophageal sonographic monitoring of tumor thrombus in the inferior vena cava during radical nephrectomy and thrombectomy for renal cell carcinoma. J Clin Ultrasound 2003; 31: 274-277. (Pubitemid 36583451)
43. Oikawa T, Shimazui T, Johraku A, Kihara S, Tsukamoto S, Miyanaga N, et al: Intraoperative transesophageal echocardiography for inferior vena caval tumor thrombus in renal cell carcinoma. Int J Urol 2004; 11: 189-192. (Pubitemid 38560320)
44. Kristensen JK, Holm HH, Rasmussen SN, Barlebo H: Ultrasonically guided percutaneous puncture of renal masses. Scand J Urol Nephrol 1972; 6(suppl 15):49S-56S.
45. Johnson PT, Nazarian LN, Feld RI, et al: Sonographically guided renal mass biopsy: indications and efficacy. J Ultrasound Med 2001; 20: 749-753. (Pubitemid 32601785)
46. Reichelt O, Gajda M, Chyhrai A, et al: Ultrasound- guided biopsy of homogenous solid renal masses. Eur Urol 2007; 52: 1421-1426.
47. Caoili EM, Bude RO, Higgins EJ, Hoff DL, Nghiem HV: Evaluation of sonographically guided percutaneous core biopsy of renal masses. AJR Am J Roentgenol 2002; 179: 373-378. (Pubitemid 34785639)
48. Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr: Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007; 188: 563-570. (Pubitemid 46167760)
49. Salagierski M, Salagierski MS, Salagierska- Barwinska A: Radiofrequency ablation in kidney tumour management: a method of real-time monitoring. Scand J Urol Nephrol 2010; 44: 84-90.
50. Lyrdal D, Andersson M, Hellström M, Sternal J, Lundstam S: Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: clinical results and radiological evolution during follow-up. Acta Radiol 2010; 51: 808-818.
51. Hoeffel C, Pousset M, Timsit MO, Elie C, Méjean A, Merran S, et al: Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 2010; 20: 1812-1821.
52. Ritchie RW, Leslie T, Phillips R, et al: Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up. BJU Int 2010;106:1004-1009.
53. Motzer RJ, Bukowski RM: Targeted therapy for metastatic renal cell carcinoma. J Clin Oncol 2006; 24: 5601-5608. (Pubitemid 46631341)
54. van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Boven E: Targeted therapies in renal cell cancer: recent developments in imaging. Target Oncol 2010; 5: 95-112.
55. Anderson SA, Rader RK,WestlinWF, et al: Magnetic resonance contrast enhancement of neovasculature with a(v β 3-targeted nanoparticles. Magn Reson Med 2000; 44: 433-439.
56. Kabakci N, Igci E, Secil M, Yorukoglu K, Mungan U, Celebi I, Kirkali Z: Echo contrast- enhanced power Doppler ultrasonography for assessment of angiogenesis in renal cell carcinoma. J Ultrasound Med 2005; 24: 747-753. (Pubitemid 40734622)
57. Lamuraglia M, Escudier B, Chami L, Schwartz B, Leclere J, Roche A, Lassau N: To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006,42: 2472-2479. (Pubitemid 44442955)
58. Lassau N, Koscielny S, Albiges L, Chami L, Benatsou B, Chebil M, Roche A, Escudier BJ: Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 2010; 16: 1216-1225.
59. Lassau N, Chami L, Benatsou B, Peronneau P, Roche A: Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 2007; 17(suppl 6):F89-F98. (Pubitemid 351337913)
60. Coll DM, Smith RC: Update on radiological imaging of renal cell carcinoma. BJU Int 2007; 99: 1217-1222. (Pubitemid 46624168)
61. Herts BR: Imaging for renal tumors. Curr Opin Urol 2003,13: 181-186. (Pubitemid 36571005)
62. Coppenrath EM, Mueller-Lisse UG: Multidetector CT of the kidney. Eur Radiol 2006; 16: 2603-2611. (Pubitemid 44649711)
63. Herts BR: Imaging for renal tumors. Curr Opin Urol 2003; 13: 181-186. (Pubitemid 36571005)
64. Coll DM, Herts BR, Davros WJ, et al: Preoperative use of 3D volume rendering to demonstrate renal tumors and renal anatomy. Radiographics 2000; 20: 431-438.
65. Yuh BL, Cohan RC: Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 1999; 173: 747-755.
66. Sheth S, Scatarige JC, Horton KM, et al: Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001; 21(Spec No):S237-S254.
67. Rankin SC, Webb JA, Reznek RH: Spiral computed tomography in the diagnosis of renal masses. BJU Int 2000; 86(suppl 1):48-57. (Pubitemid 30453639)
68. Schreyer HH, Uggowitzer MM, Ruppert- Kohlmayr A: Helical CT of the urinary organs. Eur Radiol 2002; 12: 575-591. (Pubitemid 36940102)
69. Roy C, Tuchmann C, Morel M, et al: Is there still a place for angiography in the management of renal mass lesions? Eur Radiol 1999; 9: 329-335.
70. Szolar DH, Kammerhuber F, Altziebler S, Tillich M, Breinl E, Fotter R, Schreyer HH: Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small ( < 3-cm) renal masses. Radiology 1997; 202: 211-217. (Pubitemid 27024129)
71. Fujimoto H, Wakao F, Moriyama N, Tobisu K, Sakamoto M, Kakizoe T: Alveolar architecture of clear cell renal carcinomas < or = 5.0 cm) show high attenuation on dynamic CT scanning. Jpn J Clin Oncol 1999; 29: 198-203.
72. Wildberger JE, Adam G, Boeckmann W, et al: Computed tomography characterization of renal cell tumors in correlation with histopathology. Invest Radiol 1997; 32: 596-601. (Pubitemid 28069140)
73. Kim JK, Kim TK, Ahn HJ, et al: Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002; 178: 1499-1506. (Pubitemid 34547840)
74. Jinzaki M, Tanimoto A, Mukai M, et al: Double- phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24: 835-842. (Pubitemid 32201804)
75. Herts BR, Coll DM, Novick AC, et al: Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002; 178: 367-372. (Pubitemid 34098041)
76. Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I: Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes- correlation with pathologic findings. Radiology 2009; 250: 793-802.
77. Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA: Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005; 174: 451-455. (Pubitemid 40981570)
78. Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, Eisenberg H, Hricak H: Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244: 494-504. (Pubitemid 47080882)
79. Kim JK, Park SY, Shon JH, Cho KS: Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230: 677-684. (Pubitemid 38252861)
80. Bird VG, Kanagarajah P, Morillo G, Caruso DJ, Ayyathurai R, Leveillee R, Jorda M: Differentiation of oncocytoma and renal cell carcinoma in small renal masses ( < 4 cm): the role of 4-phase computerized tomography. World J Urol 2010, Epub ahead of print.
81. Abdulla C, Kalra MK, Saini S, et al: Pseudoenhancement of simulated renal cysts in a phantom using different multidetector CT scanners. AJR Am J Roentgenol 2002; 179: 1473-1476. (Pubitemid 35386645)
82. Eshed I, Elias S, Sidi AA: Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin Radiol 2004; 59: 262-267. (Pubitemid 38268127)
83. Catalano C, Fraioli F, Laghi A, et al: Highresolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol 2003; 180: 1271-1277. (Pubitemid 36504613)
84. Yoon J, Herts BR: Staging renal cell carcinoma with helical CT: the revised 1997 AJCC and UICC TNM criteria. Crit Rev Comput Tomogr 2003; 44: 229-249. (Pubitemid 37259582)
85. Hallscheidt PJ, Bock M, Riedasch G, et al: Diagnostic accuracy of staging renal cell carcinomas using multidetector row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation. J Comput Assist Tomogr 2004; 28: 333-339. (Pubitemid 38607991)
86. Yamashita Y, Honda S, Nishiharu T, Urata J, Takahashi M: Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. AJR Am J Roentgenol 1996; 166: 1151-1155. (Pubitemid 26122963)
87. Miyazaki T, Yamashita Y, Yoshimatsu S, Tsuchigame T, Takahashi M: Renal cell carcinomas in von Hippel-Lindau disease; tumor detection and management. Comput Med Imaging Graph 2000; 24: 105-113. (Pubitemid 30184884)
88. Hallscheidt P, Wagener N, Gholipour F, et al: Multislice computed tomography in planning nephron-sparing surgery in a prospective study with 76 patients: comparison of radiological and histopathological findings in the infiltration of renal structures. J Comput Assist Tomogr 2006; 30: 869-874. (Pubitemid 44704408)
89. T̈rkvatan A, Akdur PO, Altinel M, et al: Preoperative staging of renal cell carcinoma with multidetector CT. Diagn Interv Radiol 2009; 15: 22-30.
90. Griffin N, Gore ME, Sohaib SA: Imaging in metastatic renal cell carcinoma. AJR Am J Roentgenol 2007; 189: 360-370. (Pubitemid 47195921)
91. Sawai Y, Kinouchi T, Mano M, et al: Ipsilateral adrenal involvement from renal cell carcinoma: retrospective study of the predictive value of computed tomography. Urology 2002; 59: 28-31. (Pubitemid 34059301)
92. Hallscheidt P, Pomer S, Roeren T, Kauffmann GW, Staehler G: Preoperative staging of renal cell carcinoma with caval thrombus: is staging in MRI justified? Prospective histopathological correlated study. Urologe A 2000; 39: 36-40. (Pubitemid 30163154)
93. Myneni L, Hricak H, Carroll PR: Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol 1991; 68: 571-578.
94. Lawrentschuk N, Gani J, Rowden R, et al: Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005; 96: 291-295. (Pubitemid 41097668)
95. Hallscheidt PJ, Fink C, Haferkamp A, et al: Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr 2005; 29: 64-68. (Pubitemid 40194440)
96. Guo HF, Song Y, Na YQ: Value of abdominal ultrasound scan, CT and MRI for diagnosing inferior vena cava tumour thrombus in renal cell carcinoma. Chin Med J 2009; 122: 2299-2302.
97. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
98. Van der Veldt AA, Meijerink MR, Van den Eertwegh AJ, Haanen JB, Boven E: Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Br J Cancer 2010; 102: 803-809.
99. Smith AD, Lieber ML, Shah SN: Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol 2010; 194: 157-165.
100. Han KS, Jung DC, Choi HJ, JeongMS, Cho KS, Joung JY, Seo HK, Lee KH, Chung J: Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy. Cancer 2010; 116: 2332-2342.
101. Wang JH, Min PQ, Wang PJ, Cheng WX, Zhang XH, Wang Y, Zhao XH, Mao XQ: Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 2006; 186: 1423-1430. (Pubitemid 46112581)
102. Glockner JF, Hu HH, Stanley DW, Angelos L, King K: Parallel MR imaging: a user's guide. Radiographics 2005; 25: 1279-1297.
103. Outwater EK, Blasbalg R, Siegelman ES, Vala M: Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. Radiographics 1998; 18: 1465-1480. (Pubitemid 128467071)
104. Yoshimitsu K, Honda H, Kuroiwa T, et al: MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemicalshift gradient-echo imaging. J Magn Reson Imaging 1999; 9: 579-585. (Pubitemid 29194298)
105. Pedrosa I, Chou MT, Ngo L, et al: MR classification of renal masses with pathologic correlation. Eur Radiol 2008; 18: 365-375. (Pubitemid 351234058)
106. Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D: MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 2007; 17: 193-200. (Pubitemid 46063044)
107. Tsuda K, Kinouchi T, Tanikawa G, et al: Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging. Int J Urol 2005; 12: 795-800. (Pubitemid 41726973)
108. Yabuki T, Togami I, Kitagawa T, et al: MR imaging of renal cell carcinoma: associations among signal intensity, tumor enhancement, and pathologic findings. Acta Med Okayama 2003; 57: 179-186. (Pubitemid 37386874)
109. Yoshimitsu K, Irie H, Tajima T, et al: MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 2004; 22: 371-376. (Pubitemid 40144012)
110. Oliva MR, Glickman JN, Zou KH, Teo SY, Mortelé KJ, Rocha MS, Silverman SG: Renal cell carcinoma: T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am J Roentgenol 2009; 192: 1524-1530.
111. Ho VB, Allen SF, Hood MN, Choyke PL: Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 2002; 224: 695-700. (Pubitemid 34919800)
112. Pedrosa I, Alsop DC, Rofsky NM: Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer 2009; 115(10 suppl):2334-2345.
113. Ergen FB, Hussain HK, Caoili EM, Korobkin M, Carlos RC, Weadock WJ, et al: MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 2004; 182: 217-225. (Pubitemid 38017746)
114. Nikken JJ and Krestin GP: MRI of the kidney - state of the art. Eur Radiol 2007; 17: 2780-2793. (Pubitemid 47603973)
115. Yamashita Y, Honda S, Nishiharu T, Urata J, Takahashi M: Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. AJR Am J Roentgenol 1996; 166: 1151-1155. (Pubitemid 26122963)
116. Takahashi S, Ueda J, Furukawa T, et al: Renal cell carcinoma: preoperative assessment for enucleative surgery with angiography, CT, and MRI. J Comput Assist Tomogr 1996; 20: 863-869.
117. Kamel IR, Hochman MG, Keogan MT, Eng J, Longmaid HE 3rd, DeWolf W, Edelman RR: Accuracy of breath-hold magnetic resonance imaging in preoperative staging of organ confined renal cell carcinoma. J Comput Assist Tomogr 2004; 28: 327-332. (Pubitemid 38607990)
118. Roy C Sr, El Ghali S, Buy X, Lindner V, Lang H, Saussine C, Jacqmin D: Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study. AJR Am J Roentgenol 2005; 184: 113-120. (Pubitemid 40040914)
119. Narumi Y, Hricak H, Presti JC, et al: MR imaging evaluation of renal cell carcinoma. Abdom Imaging 1997; 22: 216-225. (Pubitemid 27087977)
120. Fein AB, Lee JK, Balfe DM, et al: Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT. AJR Am J Roentgenol 1987; 148: 749-753. (Pubitemid 17047765)
121. Zagoria RJ, Bechtold RE, Dyer RB: Staging of renal adenocarcinom: role of various imaging procedures. AJR Am J Roentgenol 1995; 164: 363-370.
122. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN: Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16: 4712-4727.
123. Kallman DA, King BF, Hattery RR, et al: Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 1992; 16: 240-247.
124. Choyke PL, Walther MM, Wagner JR, Rayford W, Lyne JC, Linehan WM: Renal cancer: preoperative evaluation with dual phase three dimensional MR angiography. Radiology 1997; 205: 767-771. (Pubitemid 27516713)
125. Oto A, Herts BR, Remer EM, Novick AC: Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment. AJR Am J Roentgenol 1998; 171: 1619-1624. (Pubitemid 28531634)
126. Flaherty KT, Rosen MA, Heitjan DF, Gallagher ML, Schwartz B, Schnall MD, O'Dwyer PJ: Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther 2008; 7: 496-501. (Pubitemid 351847022)
127. Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM: Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 2008; 26: 4572-4578.
128. Hillman GG, Singh-Gupta V, Zhang H, Al Bashir AK, Katkuri Y, Li M, Yunker CK, Patel AD, Abrams J, Haacke EM: Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. Neoplasia 2009; 11: 910-920.
129. Rosen MA, Schnall MD: Dynamic contrast- enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 2007; 13: 770s-776s.
130. de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM: Magnetic resonance imaging-measured blood Xow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res 2008; 14: 5548-5554.
131. Wahl RL, Harney J, Hutchins G, Grossman HB: Imaging of renal cancer using positron emission tomography with 2-deoxy-2- (18F)-fluoro- D -glucose: pilot animal and human studies. J Urol 1991; 146: 1470-1474.
132. Aide N, Cappele O, Bottet P, et al: Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 2003; 30: 1236-1245. (Pubitemid 37205377)
133. Ak I, Can C: F-18 FDG-PET in detecting renal cell carcinoma. Acta Radiol 2005; 46: 895-899. (Pubitemid 43102658)
134. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM: Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004; 171: 1806-1809. (Pubitemid 38501007)
135. Bachor R, Kotzerke J, Gottfried HW, et al: Positron emission tomography in diagnosis of renal cell carcinoma. Urologe [A] 1996; 35: 146-150. (Pubitemid 26130554)
136. Ramdave S, Thomas GW, Berlangieri S, et al: Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001; 166: 825-830. (Pubitemid 32750957)
137. Divgi CR, Pandit-Taskar N, Jungbluth AA, et al: Preoperative characterisation of clearcell renal carcinoma using iodine-124- labelled antibody chimeric G250 (124IcG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 2007; 8: 304-310. (Pubitemid 46464522)
138. Lawrentschuk N, Poon AMT, Foo SS, et al: Assessing regional hypoxia in human renal tumours using 18 F-fluoromisonidazole positron emission tomography. BJU Int 2005; 96: 540-546. (Pubitemid 41224324)
139. Lawrentschuk N, Poon AM, Scott AM: Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumors. Clin Nucl Med 2006; 31: 788-789. (Pubitemid 44789558)
140. Brouwers AH, Dorr U, Lang O, et al: 131 IcG250 monoclonal antibody immunoscintigraphy versus [ 18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nucl Med Commun 2002; 23: 229.
141. Safaei A, Figlin R, Hoh CK, et al: The usefulness of F-18 deoxyglucose wholebody positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002; 57: 56.
142. Majhail NS, Urbain JL, Albani JM, et al: F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003; 21: 3995-4000. (Pubitemid 46606214)
143. Jadvar H, Kherbache HM, Pinski JK, Conti PS: Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol 2003; 60: 395-400. (Pubitemid 38196188)
144. Wu HC, Yen RF, Shen YY, Kao CH, Lin CC, Lee CC: Comparing whole-body 18F-2-deoxyglucose positron emission tomography and technetium-99 m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas: a preliminary report. J Cancer Res Clin Oncol 2002; 128: 503-506.
145. Park JW, Jo MK, Lee HM: Significance of 18 F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. BJU Int 2008; 103: 615-619.
146. Sizemore AW, Jacobs MP, Mantil JC, Hahm GK: FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography. Clin Nucl Med 2007; 32: 309-311. (Pubitemid 46569322)
147. García JR, Simo M, Huguet M, Ysamat M, Lomena F: Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma. Clin Transl Oncol 2006; 8: 124-128.
148. Davidson T, Goitein O, Avigdor A, Zwas ST, Goshen E: 18 F-FDG-PET/CT for the diagnosis of tumor thrombosis. Isr Med Assoc J 2009; 11: 69-73.
149. Lyrdal D, Boijsen M, Suurk̈la M, Lundstam S, Stierner U: Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-xuoro-2-deoxyglucose positron emission tomography and computed tomography. Nucl Med Commun 2009; 30: 519-524.
150. Vercellino L, Bousquet G, Baillet G, Barré E, Mathieu O, Just PA, Desgrandchamps F, Misset JL, Hindié E, Moretti JL: 18 F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study. Cancer Biother Radiopharm 2009; 24: 137-144.
151. Anderson H, Yap JT, Wells P, Miller MP, Propper D, Price P, Harris AL: Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane. Br J Cancer 2003; 89: 262-267. (Pubitemid 36976313)
152. Schöder H, Larson SM: Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34: 274-292. (Pubitemid 39365998)